SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Edison International is a renewable energy company, which operates through its subsidiaries. It supplies and distributes electric power, and also invests in energy services and technologies. The company was founded on July 4, 1886, and is headquartered in Rosemead, CA.

Edison International

Edison International is trending following a significant sell-off driven by investor concerns over potential wildfire liability linked to company infrastructure, with the community divided between those bracing for further downside from litigation and those viewing the dip as an attractive entry point for a resilient utility. Sentiment has been recently bolstered by news that the company has identified a homeless encampment near the fire's reported origin, leading some traders to speculate that liability claims may be mitigated.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E Corp shares are trending after Bank of America downgraded the stock following the failure of Senate Bill 492 to pass, which investors hoped would provide stronger protections against wildfire-related financial liabilities. While the downgrade sparked significant negative sentiment, some traders expressed skepticism regarding the selloff, describing it as an overreaction to legislative developments.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as traders focus on the anticipated Phase 3 ORIGIN 3 eGFR analysis readout expected in the third quarter. Discussion highlights a divide between investors anticipating a positive catalyst or potential acquisition, and others expressing concern over competition and recent price volatility.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology shares experienced significant volatility following a fiscal first-quarter earnings report that featured revenue and earnings beats but faced selling pressure amid high investor growth expectations. While the price declined, community sentiment remains notably optimistic, with many traders viewing the pullback as a buying opportunity based on the company's long-term AI-driven growth trajectory.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is currently trending as traders debate the ETF's near-term technical outlook amid a broader discussion on gold's role as a hedge against fiscal instability, high debt, and potential Fed rate policy shifts. Market participants are divided between those anticipating a tactical pullback and others maintaining long-term bullish positions based on the sector's performance relative to physical gold and macroeconomic uncertainty.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors react to the company securing a significant 482 MW power agreement at its Kentucky campus, which many in the community view as a critical step in scaling its AI and high-performance computing infrastructure. While bulls express confidence in the company's long-term growth and its pivot toward hyperscale hosting, bears and some traders remain skeptical due to ongoing downward price momentum, recent insider selling, and broader sector-wide weakness.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific (APAC). Its brands include Abercrombie and Hollister. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is experiencing heavy volatility and high trading volume following a strong earnings report that featured record revenue and raised full-year guidance, though traders remain divided over the extent to which one-time tariff refunds inflated the results. While some investors view the stock as an undervalued cash-generating machine with aggressive buybacks, a vocal group of traders continues to short the stock, labeling it a valuation trap that is overdue for a significant pullback.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trading with increased volatility and upward momentum as investors anticipate the upcoming Robotaxi and Cybercab launch event. While some traders express skepticism regarding the company's autonomous vehicle timelines and valuation, bullish sentiment is being driven by rising enthusiasm for the event and expanding robotaxi testing in Texas.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending lower as investors digest escalating military tensions between the U.S. and Iran, which have driven oil prices higher and pushed Treasury yields to multi-year peaks. The market remains sensitive to concerns that these inflationary pressures could complicate the Federal Reserve's upcoming rate decision, fueling debates over the sustainability of current equity valuations.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate is trending primarily due to positive community sentiment surrounding its fiscal Q4 earnings beat and strong forward-looking guidance, which investors view as evidence of sustained demand for high-capacity storage despite broader sector volatility. Traders are closely watching the company's performance as a bellwether for AI infrastructure spending, with many viewing the recent price dips as buying opportunities amidst continued long-term demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp

Outlook Therapeutics targets a year-end 2026 U.S. LYTENAVA launch, with $50M-$75M in first-year net revenues and a ramp tied to reimbursement.

Transcript: Outlook Therapeutics Q3 2026 Earnings Conference Call

Outlook Therapeutics (NASDAQ:OTLK) released third-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...

Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Outlook Therapeutics, Inc. (OTLK) delivered earnings and revenue surprises of 0.00% and -99.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Outlook Therapeutics (NASDAQ: OTLK) to release Q3 earnings on Aug. 14. Analysts expect a loss of 8 cents/share. Analysts rate it Neutral or Buy.read more...

Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates

Zealand Pharma AS (ZLDPF) delivered earnings and revenue surprises of +2,150.00% and +756.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Did OTLK Stock Crash In Pre-Market Today?

Equity

Outlook Therapeutics is looking to sell about 55.6 million common shares, accompanied by warrants, at a 10% discount over the stock’s closing price on Wednesday.

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Outlook Therapeutics rallies 311.8% in three months as Lytenava's FDA approval boosts optimism ahead of its planned U.S. launch by year-end.

iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates

IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +5,900.00% and +2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Outlook Therapeutics, Inc. (OTLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Outlook Therapeutics to Report Q3 Earnings: What's in the Cards?

OTLK heads into Q3 results with investors watching European Lytenava sales, U.S. launch plans and updates after its landmark FDA approval.

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

• Reported GAAP EPS of -$0.15 up 72.73% YoY
• Reported revenue of $0.01M down -99.40% YoY

Outlook Therapeutics reported a significant year-over-year revenue decline to $9 thousand, a persistent net loss of $20.3 million, and exposure to unpredictable macroeconomic risks and ongoing global conflicts for Outlook Therapeutics.

Outlook Therapeutics achieved FDA approval for LYTENAVA, which the company expects will drive a significant market opportunity with potential for over $500 million in annual U.S. sales by 2030 for Outlook Therapeutics.

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Extremely Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	-$0.07	--	--	N/A
Q3 '26	-$0.08	-$0.14	-75.00%	MISSED
Q2 '26	-$0.12	-$0.16	-32.05%	MISSED
Q1 '26	-$0.23	-$0.22	2.94%	BEAT
Q4 '25	-$0.23	-$0.06	74.29%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '26

Historical Earnings